Based on the data, I would recommend a SELL. Here's a brief justification:

* The trailing PE is high at 32.55, indicating that the stock is overvalued.
* The forward PE is even higher at 49.73, suggesting that the market is expecting high growth, which may not be justified given the negative earnings growth rate of -0.096.
* The ROE is decent at 22.84%, but it's not exceptional considering the industry and market conditions.
* The debt-to-equity ratio is relatively high at 26.25, which may be a concern.
* The profit margin is moderate at 13.96%, but the revenue growth rate is low at 10.8%, which may indicate slowing growth.

Overall, considering these factors, I believe that the potential upside is limited, and the stock's current valuation is not justified. Therefore, I would recommend selling the stock.